Related Experiment Video
Updated: Aug 12, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Effect of prenatal opioid exposure on cholinergic development
1Department of Pharmacology and Toxicology, Medical College of Virginia, Campus of Virginia Commonwealth University, Richmond, VA 23298-0613, USA. serobins@hsc.vcu.edu
Opioid medications like methadone and buprenorphine, used during pregnancy, may disrupt fetal brain development. Prenatal opioid exposure can alter acetylcholine pathways in the developing brain, impacting long-term neurological function.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Opioid medications (e.g., methadone, buprenorphine) are common in managing pregnant addiction.
- These treatments are generally considered safe, avoiding in utero withdrawal.
- Emerging evidence suggests potential neurodevelopmental impacts.
Purpose of the Study:
- To investigate the effects of perinatal opioid exposure on cholinergic development in the rat striatum.
- To examine the long-term consequences of prenatal opioid exposure on neurotransmitter systems.
Main Methods:
- Assessed acetylcholine (ACh) content, choline acetyltransferase (ChAT) protein, and mRNA expression in early postnatal rats.
- Measured ACh turnover rates in adult rats exposed to opioids prenatally.
- Investigated potential mechanisms involving nerve growth factor (NGF).
Main Results:
- Prenatal opioid exposure reduced ACh content and ChAT expression in early development.
- While these markers normalized over time, ACh turnover rates remained elevated in adulthood.
- Opioid exposure decreased nerve growth factor expression, suggesting a potential mechanism.
Conclusions:
- Perinatal opioid exposure disrupts cholinergic development, with lasting effects on neuronal activity.
- The findings highlight potential long-term neurological risks associated with prenatal opioid exposure.
- Altered nerve growth factor expression may mediate these developmental disruptions.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...